Monoclonal antibodies in the treatment of central nervous system malignancies
- 31 March 1992
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (2-3) , 511-513
- https://doi.org/10.1016/s0959-8049(05)80090-5
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Intrathecal administration of 131I radiolabelled monoclonal antibody as a treatment for neoplastic meningitisBritish Journal of Cancer, 1990
- Quantitative distribution of 131I-labelled monoclonal antibodies administered by the intra-ventricular routeEuropean Journal of Cancer and Clinical Oncology, 1990
- Preliminary trial of specific targeting therapy against malignant gliomaThe Lancet, 1990
- The role of chemotherapy in the treatment of gliomas in adultsCancer Treatment Reviews, 1989
- A pilot study of131I monoclonal antibodies in the therapy of leptomeningeal tumorsCancer, 1988
- Quantitative and qualitative aspects of radiolocalization in colon cancer patients of intravenously administered MAb B72.3International Journal of Cancer, 1987
- 131-I Coupled to Monoclonal Antibodies as Therapeutic Agents for Neuroectodermally Derived Tumors: Fact or Fiction?Cancer Drug Delivery, 1986